Suven Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on June 24, 2022, inter alia, to consider matters related to raising of funds through issue of equity shares of the Company on rights basis to the existing equity shareholders of the Company in accordance with provisions of Companies Act, 2013 and SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and other matters related/ incidental thereto including the constitution of a Committee of Board of Directors namely 'Rights Issue Committee' to implement the proposal of Rights Issue.<BR><BR>In this connection, in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended and in terms of the Code of Conduct of the Company for prevention of Insider Trading, the "Trading Window" for dealing in the securities of the<BR>Company shall remain closed from 21st June 2022 to 26th June 2022 (both days inclusive) for the Directors, Promoters, other Designated Persons, and immediate relatives of Designated Persons covered under the said code read with the SEBI Regulations,. Further, Trading window will be opened from 27th June, 2022.<BR>
|